Human Longevity Venture Fund

Human Longevity Venture Fund appears to be an investment vehicle rather than a drug-development operating company. Publicly available evidence for a distinct active company under this exact name is very limited, and search results primarily resolve to Human Longevity, a precision health and longevity company founded by J. Craig Venter, rather than to a standalone venture-backed biotech developer or healthcare services operator. Based on the available information, this entity is best characterized as an inactive or poorly documented longevity-focused investment fund with no identifiable therapeutic pipeline, clinical programs, or commercial products under this exact name. Because the requested name does not map cleanly to a well-documented operating biotech/pharma company, many operating-company fields are not applicable.